Page last updated: 2024-08-21

boldenone and Prostatic Neoplasms

boldenone has been researched along with Prostatic Neoplasms in 16 studies

Research

Studies (16)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (18.75)	18.7374
1990's	5 (31.25)	18.2507
2000's	7 (43.75)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (6.25)	2.80

Authors

Authors	Studies
Caron, P; Ding, K; Guillemette, C; Klotz, L; Lacombe, L; Lévesque, É; Morin, F; Neveu, B; Pouliot, F; Rouleau, M; Toren, P; Vélot, L	1
Cook, LM; Eltoum, IA; Harper, CE; Lamartiniere, CA; Patel, BB; Shirai, T; Wang, J	1
Carter, J; Chatta, G; Dahut, WL; Figg, WD; Gulley, JL; Higano, CS; Hussain, MH; Petrylak, DP; Sartor, O; Steinberg, SM	1
Kumagai, T; Shimizu, T; Takeda, K; Tomari, K	1
Alimirah, F; Basrawala, Z; Chen, J; Choubey, D; Xin, H	1
Hara, S; Hyochi, N; Isaacs, JT; Ishioka, J; Kageyama, Y; Kihara, K; Singh, P; Urushibara, M	1
Allen, JD; Arnold, JT; Blackman, MR; Le, H; Liu, X; McFann, KK	1
Lin, FF; Lin, MF; Veeramani, S; Yuan, TC	1
Allen, JM; Bloom, SR; Kerle, D; O'Shea, JP; Smith, C; Williams, G; Yeo, T	1
Brown, NM; Chung, LW; Gleave, ME; Hsieh, JT; Pathak, S; Wu, HC	1
Iversen, P	1
Severin, ES; Zezerov, EG	1
Baisch, H; Fack, H; Otto, U	1
Chung, LW; Gleave, ME; Hsieh, JT; von Eschenbach, AC; Wu, HC	1
Isurugi, K	1
de Jong, FH; Reuvers, PJ; Schroeder, FH; van Dongen, JJ; van Steenbrugge, GJ	1

Reviews

2 review(s) available for boldenone and Prostatic Neoplasms

Article	Year
Combined androgen blockade in the treatment of advanced prostate cancer--an overview. The Scandinavian Prostatic Cancer Group. Scandinavian journal of urology and nephrology, 1997, Volume: 31, Issue:3 Topics: Androgen Antagonists; Chemotherapy, Adjuvant; Combined Modality Therapy; Humans; Male; Orchiectomy; Premedication; Prostate; Prostatectomy; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Testis; Testosterone	1997
[Molecular mechanisms of prostatic oncogenesis]. Vestnik Rossiiskoi akademii meditsinskikh nauk, 1998, Issue:5 Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Animals; Biomarkers, Tumor; Cell Division; Epithelium; Genes, Tumor Suppressor; Humans; Insulin-Like Growth Factor Binding Protein 3; Male; Oncogenes; Prognosis; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Stromal Cells; Testosterone	1998

Article

Year

Combined androgen blockade in the treatment of advanced prostate cancer--an overview. The Scandinavian Prostatic Cancer Group.

Scandinavian journal of urology and nephrology, 1997, Volume: 31, Issue:3

Topics: Androgen Antagonists; Chemotherapy, Adjuvant; Combined Modality Therapy; Humans; Male; Orchiectomy; Premedication; Prostate; Prostatectomy; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Testis; Testosterone

1997

[Molecular mechanisms of prostatic oncogenesis].

Vestnik Rossiiskoi akademii meditsinskikh nauk, 1998, Issue:5

Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Animals; Biomarkers, Tumor; Cell Division; Epithelium; Genes, Tumor Suppressor; Humans; Insulin-Like Growth Factor Binding Protein 3; Male; Oncogenes; Prognosis; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Stromal Cells; Testosterone

1998

Trials

2 trial(s) available for boldenone and Prostatic Neoplasms

Article	Year
Extragonadal Steroids Contribute Significantly to Androgen Receptor Activity and Development of Castration Resistance in Recurrent Prostate Cancer after Primary Therapy. The Journal of urology, 2020, Volume: 203, Issue:5 Topics: Anabolic Agents; Androgens; Androstenedione; Biomarkers, Tumor; Castration; Cell Line, Tumor; Follow-Up Studies; Humans; Male; Mass Spectrometry; Neoplasm Recurrence, Local; Prospective Studies; Prostate; Prostatic Neoplasms; Receptors, Androgen; Testosterone; Time Factors	2020
A prospective analysis of the time to normalization of serum androgens following 6 months of androgen deprivation therapy in patients on a randomized phase III clinical trial using limited hormonal therapy. The Journal of urology, 2005, Volume: 173, Issue:5 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Testosterone; Time Factors	2005

Article

Year

Extragonadal Steroids Contribute Significantly to Androgen Receptor Activity and Development of Castration Resistance in Recurrent Prostate Cancer after Primary Therapy.

The Journal of urology, 2020, Volume: 203, Issue:5

Topics: Anabolic Agents; Androgens; Androstenedione; Biomarkers, Tumor; Castration; Cell Line, Tumor; Follow-Up Studies; Humans; Male; Mass Spectrometry; Neoplasm Recurrence, Local; Prospective Studies; Prostate; Prostatic Neoplasms; Receptors, Androgen; Testosterone; Time Factors

2020

A prospective analysis of the time to normalization of serum androgens following 6 months of androgen deprivation therapy in patients on a randomized phase III clinical trial using limited hormonal therapy.

The Journal of urology, 2005, Volume: 173, Issue:5

Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Testosterone; Time Factors

2005

Other Studies

12 other study(ies) available for boldenone and Prostatic Neoplasms

Article	Year
Characterization of SV-40 Tag rats as a model to study prostate cancer. BMC cancer, 2009, Jan-26, Volume: 9 Topics: Age Factors; Androgen-Binding Protein; Animals; Antigens, Polyomavirus Transforming; Apoptosis; Blotting, Western; Cell Proliferation; Disease Models, Animal; Estradiol; Insulin-Like Growth Factor I; Male; Neoplasm Proteins; Precancerous Conditions; Prostate; Prostatic Neoplasms; Rats; Simian virus 40; Testosterone; Time Factors	2009
Alteration of gene expression in response to bone morphogenetic protein-2 in androgen-dependent human prostate cancer LNCaP cells. International journal of molecular medicine, 2006, Volume: 17, Issue:2 Topics: Androgens; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Male; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Testosterone; Transforming Growth Factor beta; Up-Regulation	2006
DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation. FEBS letters, 2006, Apr-17, Volume: 580, Issue:9 Topics: Active Transport, Cell Nucleus; Anabolic Agents; Antibodies; Cell Line, Tumor; Cell Nucleus; Cyclin-Dependent Kinase Inhibitor p21; Gene Expression Regulation, Neoplastic; Humans; Male; Neoplasm Proteins; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger; Testosterone	2006
Effects of steroidal and non-steroidal antiandrogens on wild-type and mutant androgen receptors. The Prostate, 2007, Jun-01, Volume: 67, Issue:8 Topics: Allylestrenol; Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Anilides; Cyproterone Acetate; Flutamide; Humans; Imidazolidines; Male; Models, Molecular; Mutagenesis, Site-Directed; Neoplasms, Hormone-Dependent; Nitriles; Plasmids; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Testosterone; Tosyl Compounds; Transcription, Genetic; Transfection	2007
Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells. The Prostate, 2007, Aug-01, Volume: 67, Issue:11 Topics: Androgen Antagonists; Androgen Receptor Antagonists; Anilides; Cell Division; Cell Line, Tumor; Dehydroepiandrosterone; Estradiol; Estrogen Antagonists; Estrogen Receptor beta; Fulvestrant; Gene Expression; Humans; Male; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger; RNA, Small Interfering; Testosterone; Tosyl Compounds	2007
Mitochondrial redox signaling by p66Shc is involved in regulating androgenic growth stimulation of human prostate cancer cells. Oncogene, 2008, Aug-28, Volume: 27, Issue:37 Topics: Adaptor Proteins, Signal Transducing; Androgens; Cell Proliferation; Cytochromes c; Disease Progression; Humans; Male; Mitochondria; Models, Biological; Neoplasms, Hormone-Dependent; Oxidation-Reduction; Prostatic Neoplasms; Protein Binding; Reactive Oxygen Species; Shc Signaling Adaptor Proteins; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 1; Testosterone; Tumor Cells, Cultured	2008
The effect of previous endocrine therapy on responses to a single dose of an LHRH analogue. Urological research, 1984, Volume: 12, Issue:5 Topics: Adenocarcinoma; Buserelin; Castration; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Prostatic Neoplasms; Testosterone	1984
Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. International journal of cancer, 1994, May-01, Volume: 57, Issue:3 Topics: Animals; Bone and Bones; Cell Communication; Cell Division; Gene Expression Regulation, Neoplastic; Humans; Karyotyping; Male; Mice; Mice, Nude; Neoplasm Transplantation; Orchiectomy; Prostatic Neoplasms; Stromal Cells; Testosterone; Tumor Cells, Cultured	1994
Growth of human prostate carcinomas with and without hormone alpha- dehydrotestosterone in nude mice. European urology, 1998, Volume: 34, Issue:6 Topics: Animals; Antimetabolites, Antineoplastic; Bromodeoxyuridine; Cell Division; Disease Progression; DNA, Neoplasm; Drug Implants; Flow Cytometry; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Prostatic Neoplasms; Testosterone; Transplantation, Heterologous; Tumor Cells, Cultured	1998
Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors. Cancer research, 1992, Mar-15, Volume: 52, Issue:6 Topics: Animals; Antigens, Neoplasm; Biomarkers, Tumor; Growth Substances; Half-Life; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; RNA, Messenger; Testosterone; Tumor Cells, Cultured	1992
[Clinical application of serum DHT determination]. Nihon rinsho. Japanese journal of clinical medicine, 1989, Volume: 48 Suppl Topics: Adult; Age Factors; Chorionic Gonadotropin; Disorders of Sex Development; Humans; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Radioimmunoassay; Reference Values; Testosterone	1989
Transplantable human prostatic carcinoma (PC-82) in athymic nude mice: I. Hormone dependence and the concentration of androgens in plasma and tumor tissue. The Prostate, 1987, Volume: 11, Issue:2 Topics: Adenocarcinoma; Androgens; Animals; Castration; Estradiol; Female; Male; Mice; Mice, Nude; Neoplasm Transplantation; Prostatic Neoplasms; Testosterone	1987